Delivery Order SPE2DX15D3306-SPE2DX23FADCA
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $13,266.82 firm fixed price delivery order is for TRELEGY ELLIPTA 200-62.5-25 60S, a specialty pharmaceutical product. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical with a potential...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the leading global pharmaceutical company Amerisourcebergen Corporation. The $2,184.04 firm fixed price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the...
- This federal contract award, with ID SPE2DX15D2109|SPE2DX24F0J4P, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $10,404.91 firm fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The award has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal healthcare...
- This federal contract award, valued at $6,785.54, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a delivery order (SPE2DX15D3021|SPE2DX24F1LR1) for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. The award has an ultimate completion date of May 10, 2024 and is a firm fixed-price contract. No set-aside designation was used. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is a Delivery Order valued at $2,348.79. The contract was awarded by the Defense Logistics Agency (DLA) and is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The award does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $6,723.57 firm fixed-price delivery order is for the pharmaceutical product TRELEGY ELLIPTA 200-62.5-25 60S. The contract has an ultimate completion date of July 31, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, and this award is likely part...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,499.68, is a firm fixed price delivery order that is not subject to any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor on this award, which falls under a larger indefinite delivery contract...
- This federal contract award, valued at $10,072.06, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) for the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded numerous federal...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, a firm fixed price delivery order valued at $2,259.72, is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Trelegy Ellipta 100-62.5-25 60S medication. The $5,456.23 firm fixed-price delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
- SPE2DX15D3306Indefinite Delivery Contract
- SPE2DX15D3306-SPE2DX23FADCADelivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,102.06, is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a specialty pharmaceutical product. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.1k | 9/20/23 |